Evidence map›Paper›PMID 25969693›Full record

ArticleInfectious agents and cancer2015

HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.

Cinzia Campari, Chiara Fedato, Alessio Petrelli, Manuel Zorzi, Carla Cogo, Adele Caprioglio, Federica Gallo, Livia Giordano, Serena Domenighini, Luigi Pasquale and 4 more

Abstract read
In one paragraph

Article in Infectious agents and cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cinzia CampariStaff Programmazione e Controllo, AUSL, Reggio Emilia, Italy ; IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Chiara FedatoCoordinamento regionale screening oncologici, Regione Veneto, Venezia, Italy.
Alessio PetrelliINMP Istituto Nazionale per la promozione della salute delle popolazioni Migranti ed il contrasto delle malattie della Povertà, Rome, Italy.
Manuel ZorziRegistro Tumori del Veneto, Regione Veneto, Padova, Italy.
Carla CogoRegistro Tumori del Veneto, Regione Veneto, Padova, Italy.
Adele CaprioglioUnità di Epidemiologia - CPO Piemonte, Torino, Italy.
Federica GalloUnità di Epidemiologia - CPO Piemonte, Torino, Italy.
Livia GiordanoUnità di Epidemiologia - CPO Piemonte, Torino, Italy.
Serena DomenighiniASL Valle Camonica Sebino, Breno, BS Italy.
Luigi PasqualeASL Valle Camonica Sebino, Breno, BS Italy.
Sonia PrandiPatologia IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
Marco ZappaISPO - Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy.
Paolo Giorgi RossiIRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy ; Servizio Interaziendale di Epidemiologia, AUSL, Reggio Emilia, Italy.
GISCi Migrant Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledᅟ: Immigrants from low- and medium-income countries have a higher risk of cervical cancer due both to barriers in access to screening and to higher human papillomavirus (HPV) prevalence. In the near future many screening programmes in industrialised countries will replace Pap test with HPV as primary test. In order to plan future interventions, it is essential to understand how the HPV screening performs in immigrant women.

methodsWe conducted a survey on the main performance indicators from some of the HPV DNA-based pilot programmes in Italy, comparing regular immigrant women, identified as women resident in Italy who were born abroad, with women who were born in Italy. All the programmes applied the same protocol, with HPV as stand-alone test starting for women of 25 or 35 to 64 years of age. Cytology triage is performed for positive women; those ASC-US or more severe are referred directly to colposcopy; negative women are referred to repeat HPV after one year.

resultsOverall, 162,829 women were invited, of whom 22,814 were born abroad. Participation was higher for Italy-born than born abroad (52.2% vs. 43.6%), particularly for women over 45 years. HPV positivity rate was higher in immigrants: 7.8% vs. 6.1%, age-adjusted Relative Risk (age-adj RR) 1.18, 95% confidence interval (95% CI) 1.13-1.22. The proportion of women with positive cytology triage was similar in the two groups (42%). Cervical Intraepithelial Neoplasia (CIN) grade 2 or more severe detection rate was higher for born abroad (age-adj RR 1.65, 95% CI 1.45-1.89). The difference was stronger when considering only CIN3 or more severe (age-adj RR 2.29, 95% CI 1.90-2.75). Both HPV positivity and CIN2 or more severe detection rate had a different age curve in born abroad compared with Italy-born: in the former, the risk was almost flat, while in the latter it declined rapidly with age.

conclusionCompliance with HPV screening is lower for migrant women, who are affected by higher HPV positivity and CIN3 cancer detection rates.

Identifiers

PMID25969693
PMCPMC4427984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.